Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass (2017)
- Authors:
- USP affiliated authors: SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; CARMONA, MARIA JOSE CARVALHO - FM ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidades: FCF; FM
- Subjects: CIRURGIA TORÁCICA; FARMACOCINÉTICA; FARMACODINÂMICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 53, suppl. 3, p. 80 res. CFSP142, 2017
- Conference titles: Pharmaceutical Congress of São Paulo
-
ABNT
SILVA FILHO, Carlos Roberto da et al. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2025. , 2017 -
APA
Silva Filho, C. R. da, Barbosa, R. A. G., Silva Junior, C. V. da, Carmona, M. J. C., Gomez, D. de S., & Santos, S. R. C. J. (2017). Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Silva Filho CR da, Barbosa RAG, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 80 res. CFSP142.[citado 2025 nov. 18 ] -
Vancouver
Silva Filho CR da, Barbosa RAG, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 80 res. CFSP142.[citado 2025 nov. 18 ] - Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome
- Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic
- A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients
- Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains?
- PK/PD correlation of vancomycin for dose adjustment for the control of infections in pediatric critical burn patients
- Correlação PK/PD de carbapenêmicos em pacientes críticos pediátricos grandes queimados para o controle da sepse
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose
- Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?
- Vancomycin pk/pd correlation for the control of infection in critical burn patients with sepsis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
